ANVS – Annovis Bio, Inc. Shareholder Alert – Class Action Filed
Securities Class Action Investigation – Annovis Investors Who Purchased, Or Otherwise Acquired, ANVS Securities Between May 21, 2021 and July 28, 2021, Both Dates Inclusive, And Suffered Losses Encouraged To Contact Kehoe Law Firm, P.C.
Kehoe Law Firm, P.C. is investigating whether Annovis Bio, Inc. (“Annovis” or the “Company”) (NYSE: ANVS) violated federal securities laws.
Annovis investors who purchased, or otherwise acquired, Annovis securities between May 21, 2021 and July 28, 2021 (“Class Period”) and suffered financial losses are encouraged to contact Kehoe Law Firm, P.C. to learn more about the securities class action investigation or potential securities claims.
Annovis investors should be aware that a class action lawsuit was filed against Annovis on August 17, 2021 in United States District Court, Eastern District of Pennsylvania, on behalf persons and entities that purchased, or otherwise acquired, Annovis securities between May 21, 2021 and July 28, 2021, both dates inclusive. The class action lawsuit is pursuing claims against the Annovis Defendants under the Securities Exchange Act of 1934.
ANNOVIS SHAREHOLDERS WHO PURCHASED, OR OTHERWISE ACQUIRED, THE COMPANY’S SECURITIES DURING THE CLASS PERIOD AND SUFFERED FINANCIAL LOSSES ARE ENCOURAGED TO COMPLETE KEHOE LAW FIRM’S SECURITIES CLASS ACTION QUESTIONNAIRE OR CONTACT MICHAEL YARNOFF, ESQ., (215) 792-6676, EXT. 804, [email protected], [email protected], TO DISCUSS THE SECURITIES CLASS ACTION INVESTIGATION OR POTENTIAL LEGAL CLAIMS.